Achilles Therapeutics plc Holds General Meeting
| Field | Detail |
|---|---|
| Company | Achilles Therapeutics PLC |
| Form Type | 6-K |
| Filed Date | Mar 20, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, shareholder-meeting
TL;DR
Achilles Therapeutics held its meeting on 3/20/25, 42.5M shares outstanding.
AI Summary
On March 20, 2025, Achilles Therapeutics plc held its General Meeting. As of that date, the company had 42,585,094 ordinary shares outstanding. The filing does not disclose the specific outcomes or resolutions passed at the meeting.
Why It Matters
This filing confirms the date of the General Meeting and the number of outstanding shares as of that date, providing basic corporate governance information.
Risk Assessment
Risk Level: low — The filing is a routine corporate update and does not contain significant financial or operational news.
Key Numbers
- 42,585,094 — Ordinary Shares Outstanding (As of the General Meeting date, March 20, 2025.)
Key Players & Entities
- Achilles Therapeutics plc (company) — Registrant
- March 20, 2025 (date) — Date of General Meeting and share count
- 42,585,094 (dollar_amount) — Number of ordinary shares outstanding
FAQ
What was the purpose of the General Meeting held by Achilles Therapeutics plc on March 20, 2025?
The filing states that a General Meeting was held on March 20, 2025, but does not specify the purpose or any resolutions.
How many ordinary shares did Achilles Therapeutics plc have outstanding as of March 20, 2025?
As of March 20, 2025, Achilles Therapeutics plc had 42,585,094 ordinary shares outstanding.
Is this filing an annual report or a periodic update?
This is a Form 6-K, which is a Report of Foreign Private Issuer, typically used for periodic reporting of material information.
What is the principal executive office address for Achilles Therapeutics plc?
The principal executive offices are located at 3rd Floor, 1 Ashley Road, Altrincham, Cheshire WA14 2DT, United Kingdom.
Does Achilles Therapeutics plc file annual reports under Form 20-F?
Yes, the filing indicates that the registrant files annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on March 20, 2025 regarding Achilles Therapeutics plc.